Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation.
Ochratoxin A (OTA) is nephrotoxic to all animal species, carcinogenic for rats and mice and probably implicated in human Balkan endemic nephropathy and the associated urothelial tract tumour. Controversial results concerning genotoxicity and biotransformation of OTA have been generated. By (32)P post-labelling technique, a dose- and time-dependent DNA adduct formation is observed in vivo and in vitro. Use of several inducers or inhibitors of biotransforming enzymes (including cytochrome P 450, cyclooxygenase, lipoxygenase, glutathione-S-transferase), demonstrated that OTA is biotransformed into genotoxic derivatives damaging for DNA. Authentic C8dG-OTA standards have been synthesized by photo-oxidation. Both of them (C-C8 & O-C8) co-migrate on TLC with two adducts formed by in vitro incubation of OTA in the presence of kidney microsomes, and in vivo in kidney of pig or rodent fed OTA as well as in kidney and bladder tumour of humans exposed to OTA. Several OTA metabolites have been isolated from tissues or cells treated by OTA. The open ring lactone (OP-OTA) and quinone OTA (OTQ) are genotoxic.
Pfohl-Leszkowicz
A
A
INP/ENSAT, UMR CNRS/INPT/UPS 5503, Department Bioprocess & Microbial Engineering, 1 Avenue Agrobiopole, Auzeville-Tolosane, France. leszkowicz@ensat.fr
Castegnaro
M
M
D000818:Animals; D001711:Biotransformation; D002273:Carcinogens / Q000494:pharmacology / Q000633:toxicity; D002645:Chickens; D018736:DNA Adducts / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D051379:Mice; D008861:Microsomes; D009793:Ochratoxins / Q000493:pharmacokinetics* / Q000633:toxicity; D051381:Rats; D013552:Swine
D002273:Carcinogens; D018736:DNA Adducts; D009793:Ochratoxins; C025589:ochratoxin A